Brickwood Asset Management LLP trimmed its holdings in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) by 1.4% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 2,051,469 shares of the company’s stock after selling 29,502 shares during the quarter. Envista accounts for approximately 28.5% of Brickwood Asset Management LLP’s portfolio, making the stock its 2nd biggest holding. Brickwood Asset Management LLP’s holdings in Envista were worth $39,961,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in NVST. Alliancebernstein L.P. grew its position in Envista by 1,985.1% during the first quarter. Alliancebernstein L.P. now owns 4,550,789 shares of the company’s stock valued at $78,547,000 after buying an additional 4,332,541 shares during the period. Dimensional Fund Advisors LP grew its position in Envista by 24.0% during the first quarter. Dimensional Fund Advisors LP now owns 8,387,297 shares of the company’s stock valued at $144,760,000 after buying an additional 1,625,206 shares during the period. Pzena Investment Management LLC grew its position in Envista by 160.7% during the first quarter. Pzena Investment Management LLC now owns 2,294,257 shares of the company’s stock valued at $39,599,000 after buying an additional 1,414,080 shares during the period. Trexquant Investment LP grew its position in Envista by 243.7% during the first quarter. Trexquant Investment LP now owns 1,065,849 shares of the company’s stock valued at $18,397,000 after buying an additional 755,725 shares during the period. Finally, Gates Capital Management Inc. grew its position in Envista by 10.0% during the first quarter. Gates Capital Management Inc. now owns 5,163,745 shares of the company’s stock valued at $89,126,000 after buying an additional 469,597 shares during the period.
Envista Price Performance
NVST stock opened at $20.40 on Monday. Envista Holdings Corporation has a one year low of $14.22 and a one year high of $23.00. The company’s fifty day moving average price is $20.59 and its 200-day moving average price is $19.23. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.08 and a current ratio of 2.44. The company has a market capitalization of $3.39 billion, a PE ratio of 63.75, a price-to-earnings-growth ratio of 1.09 and a beta of 1.01.
Wall Street Analysts Forecast Growth
NVST has been the subject of several recent research reports. UBS Group boosted their target price on shares of Envista from $18.00 to $22.00 and gave the company a “neutral” rating in a research report on Tuesday, July 29th. Weiss Ratings reiterated a “sell (d)” rating on shares of Envista in a research report on Wednesday, October 8th. Stifel Nicolaus upped their price target on shares of Envista from $24.00 to $25.00 and gave the stock a “buy” rating in a research report on Friday, August 1st. Wall Street Zen lowered shares of Envista from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 30th. Finally, Zacks Research lowered shares of Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 15th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $21.08.
Check Out Our Latest Stock Analysis on NVST
Envista Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories
- Five stocks we like better than Envista
- Pros And Cons Of Monthly Dividend Stocks
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- Why is the Ex-Dividend Date Significant to Investors?
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- How is Compound Interest Calculated?
- Is Landstar the Next Big Winner in Transportation Stocks?
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
